Details for New Drug Application (NDA): 021746
✉ Email this page to a colleague
The generic ingredient in SURFAXIN is lucinactant. Additional details are available on the lucinactant profile page.
Summary for 021746
Tradename: | SURFAXIN |
Applicant: | Lees Pharm Hk |
Ingredient: | lucinactant |
Patents: | 0 |
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | SUSPENSION;INTRATRACHEAL | Strength | 8.5ML | ||||
Approval Date: | Mar 6, 2012 | TE: | RLD: | No |
Expired US Patents for NDA 021746
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Lees Pharm Hk | SURFAXIN | lucinactant | SUSPENSION;INTRATRACHEAL | 021746-001 | Mar 6, 2012 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription